Back Dictionary Export CSV
Filter: Clear
MERGED_REGIMEN_ID MERGED_TUMOUR_ID HEIGHT_AT_START_OF_REGIMEN WEIGHT_AT_START_OF_REGIMEN INTENT_OF_TREATMENT DATE_DECISION_TO_TREAT START_DATE_OF_REGIMEN MAPPED_REGIMEN CLINICAL_TRIAL CHEMO_RADIATION MERGED_PATIENT_ID BENCHMARK_GROUP
220021355 220006655 1.75 68.7 Curative (C) 2014-08-31 2014-09-03 AML 18 TRIAL 1 null 220025507 AML18 TRIAL
220021356 220013668 1.73 75 null 2019-07-23 2019-07-23 ALEMTUZUMAB + FLUDARABINE + MELPHALAN N N 220025668 ALEMTUZUMAB + FLUDARABINE + MELPHALAN
220021357 220006718 1.5 54 Curative (C) 2017-01-21 2017-02-01 Alemtuz+Fludara+Melphalan RIC MUD N N 220025802 ALEMTUZUMAB + FLUDARABINE + MELPHALAN
220021358 220006728 0 null Curative (C) 2014-12-04 2014-12-08 Dasatinib N N 220025841 DASATINIB
220021359 220022342 1.8 46.3 Curative (C) 2015-09-23 2015-11-15 AML18 PILOT TRIAL N N 220025945 PILOT TRIAL
220021360 220006749 1.68 84 Disease modification (D) 2017-01-24 2018-03-17 Rituximab N N 220025947 RITUXIMAB
220021361 220013720 0 47 Curative (C) 2014-10-27 2014-10-31 Dasatinib N N 220025965 DASATINIB
220021362 220006777 1.76 70 Curative (C) 2014-02-14 2014-02-16 AML 18 Pilot Trial null N 220026051 PILOT TRIAL
220021363 220006794 1.7 85 Curative (C) 2019-08-04 2019-08-04 Dasatinib 2 N 220026127 DASATINIB
220021364 220006797 1.72 69.4 Disease modification (D) 2017-03-21 2017-06-29 AML18 PILOT TRIAL Y N 220026128 PILOT TRIAL
220021365 220006805 0 null Disease modification (D) 2015-06-04 2015-06-18 Dasatinib N N 220026157 DASATINIB
220021366 220006819 1.7 null Disease modification (D) 2019-03-09 2019-07-20 Dasatinib 99 null 220026210 DASATINIB
220021367 220006846 1.7 58.9 Curative (C) 2017-10-13 2017-10-13 AML 18 TRIAL 1 N 220026282 AML18 TRIAL
220021368 220006868 null 72.9 Curative (C) 2017-01-16 2017-01-19 ALEMTUZUMAB + FLUDARABINE + MELPHALAN N N 220026341 ALEMTUZUMAB + FLUDARABINE + MELPHALAN
220021369 220006879 1.66 null null 2018-06-07 2018-10-24 Dasatinib N null 220026364 DASATINIB
220021370 220013816 null 71.8 Palliative (P) 2017-03-20 2017-03-20 AML 18 TRIAL N N 220026565 AML18 TRIAL
220021371 220006929 1.73 61.2 Curative (C) 2017-10-05 2017-11-16 AML18 PILOT TRIAL N N 220026587 PILOT TRIAL
220021372 220006939 1.71 75 Curative (C) 2018-04-24 2018-05-05 Alemtuz+Fludara+Melphalan RIC MUD 2 N 220026612 ALEMTUZUMAB + FLUDARABINE + MELPHALAN
220021373 220013835 1.59 72.8 Curative (C) 2014-10-02 2014-11-18 AML 18 Pilot Trial 01 N 220026693 PILOT TRIAL
220021374 220007005 1.63 72.8 Curative (C) 2016-07-25 2016-09-02 AML18 PILOT TRIAL Y N 220026840 PILOT TRIAL
220021375 220007010 1.79 null Curative (C) 2018-04-08 2018-04-08 Dasatinib 99 N 220026878 DASATINIB
220021376 220007036 1.69 59 null 2018-10-03 2018-10-06 Alemtuz+Fludara+Melphalan RIC MUD N N 220026961 ALEMTUZUMAB + FLUDARABINE + MELPHALAN
220021378 220007065 1.5 78.7 null 2018-06-11 2018-06-11 Rituximab N N 220027042 RITUXIMAB
220021379 220007090 1.78 90.4 Curative (C) 2016-11-18 2016-11-19 Alemtuz+Fludara+Melphalan RIC MUD N N 220027179 ALEMTUZUMAB + FLUDARABINE + MELPHALAN
220021380 220021869 1.69 79 Curative (C) 2015-06-13 2015-06-13 Alemtuz+Fludara+Melphalan RIC MUD N N 220027327 ALEMTUZUMAB + FLUDARABINE + MELPHALAN
220021381 220013941 1.8 98 Disease modification (D) 2018-12-18 2018-12-24 Dasatinib N N 220027456 DASATINIB
220021382 220017590 1.8 94 Curative (C) 2017-04-05 2017-04-05 Alemtuz+Fludara+Melphalan RIC MUD N N 220027491 ALEMTUZUMAB + FLUDARABINE + MELPHALAN
220021383 220007164 0 null Disease modification (D) 2016-10-26 2016-11-06 Alemtuz+Fludara+Melphalan RIC MUD N null 220027518 ALEMTUZUMAB + FLUDARABINE + MELPHALAN
220021384 220007171 null 79.3 Curative (C) 2014-05-25 2014-05-29 Alemtuz+Fludara+Melphalan RIC MUD 2 N 220027551 ALEMTUZUMAB + FLUDARABINE + MELPHALAN
220021385 220007176 1.73 91.2 Disease modification (D) 2016-06-26 2016-08-19 AML18 PILOT TRIAL Y N 220027553 PILOT TRIAL
220021386 220007198 1.7 74.4 Curative (C) 2015-07-08 2015-07-08 ALEMTUZUMAB + FLUDARABINE + MELPHALAN N Y 220027658 ALEMTUZUMAB + FLUDARABINE + MELPHALAN
220021387 220007206 1.55 0 Disease modification (D) 2015-06-01 2016-06-02 Dasatinib N N 220027665 DASATINIB
220021388 220007214 1.57 60.8 Curative (C) 2015-02-27 2015-02-27 AML18 PILOT TRIAL null N 220027691 PILOT TRIAL
220021389 220007217 1.58 0 Disease modification (D) 2016-07-01 2016-07-01 Rituximab (Maintenance) N N 220027703 RITUXIMAB
220021390 220007231 1.67 null Curative (C) 2015-12-21 2017-05-05 Dasatinib 02 N 220027754 DASATINIB
220021391 220007248 1.7 null Curative (C) 2017-08-17 2017-08-19 Alemtuz+Fludara+Melphalan RIC MUD N N 220027816 ALEMTUZUMAB + FLUDARABINE + MELPHALAN
220021392 220007267 0 74.4 Curative (C) 2015-09-03 2015-09-22 ALEMTUZUMAB + FLUDARABINE + MELPHALAN Y N 220027906 ALEMTUZUMAB + FLUDARABINE + MELPHALAN
220021393 220017625 1.66 58.5 Palliative (P) 2016-06-13 2016-06-13 AML 18 TRIAL 01 N 220027940 AML18 TRIAL
220021394 220007276 1.7 82.75 Curative (C) 2018-10-26 2018-10-28 Alemtuz+Fludara+Melphalan RIC MUD N N 220027944 ALEMTUZUMAB + FLUDARABINE + MELPHALAN
220021395 220007298 1.81 null Curative (C) 2017-05-12 2017-08-04 Dasatinib 02 N 220028118 DASATINIB
220021396 220007301 1.75 61.2 Curative (C) 2013-08-20 2013-09-26 AML18 PILOT TRIAL Y N 220028136 PILOT TRIAL
220021397 220014025 1.84 81.2 Curative (C) 2013-11-15 2013-11-15 AML 18 TRIAL N N 220028170 AML18 TRIAL
220021398 220007320 1.78 83.3 Curative (C) 2016-01-01 2016-03-22 AML 18 Pilot Trial 01 N 220028203 PILOT TRIAL
220021399 220007322 1.52 78.6 Curative (C) 2017-11-08 2017-11-14 Dasatinib N N 220028206 DASATINIB
220021400 220007325 1.65 108.2 Curative (C) 2018-08-31 2018-09-11 Alemtuz+Fludara+Melphalan RIC MUD N null 220028231 ALEMTUZUMAB + FLUDARABINE + MELPHALAN
220021401 220007339 1.8 null Curative (C) 2018-06-23 2018-06-23 AML 18 TRIAL N N 220028292 AML18 TRIAL
220021402 220014051 1.55 79 Curative (C) 2014-02-18 2014-03-01 Alemtuz+Fludara+Melphalan RIC MUD N N 220028341 ALEMTUZUMAB + FLUDARABINE + MELPHALAN
220021403 220007360 1.68 72 Curative (C) 2016-01-06 2016-04-02 Rituximab N null 220028395 RITUXIMAB
220021404 220014058 1.8 0 Disease modification (D) 2015-02-02 2015-02-02 Dasatinib N N 220028396 DASATINIB
220021405 220007364 1.56 106 Curative (C) null 2017-07-16 Dasatinib N N 220028429 DASATINIB